Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NextAR Hip Platform

K-Number: K252847 · 2026-01-09

Decision Date2026-01-09
Product CodeSBF
Advisory CommitteeNE
DecisionSubstantially Equivalent

Device Summary

NextAR Hip Platform is a medical device manufactured by Medacta International S.A.. It received FDA 510(k) clearance on 2026-01-09 under approval number K252847. The device is classified under product code SBF. It was reviewed by the NE advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NextAR Hip Platform?

NextAR Hip Platform is a medical device that received FDA 510(k) clearance on 2026-01-09. It is manufactured by Medacta International S.A.. The 510(k) number is K252847.

When was NextAR Hip Platform approved by the FDA?

NextAR Hip Platform received FDA 510(k) clearance on 2026-01-09, under approval number K252847.

What company makes NextAR Hip Platform?

NextAR Hip Platform is manufactured by Medacta International S.A..

What is the FDA product code for NextAR Hip Platform?

The FDA product code for NextAR Hip Platform is SBF.

Other Devices by Medacta International S.A.

View all 146 devices →

Related Devices (Code: SBF)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.